Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Stephen P Arneric"'
Autor:
Jonathan D. Rohrer, Nadine Tatton, Chiadi U. Onyike, Michael Gold, Stephen P. Arneric, Ajay Verma, Howard J. Rosen, Rodney Pearlman, Bradley F. Boeve, Carole Ho, Robert N. Schuck, Howard Fillit, Mario Masellis, William J. Marks, Sabrina Paganoni, Earl Ray Dorsey, Kenneth Rockwood, Robert H. Paul, Michael C. Irizarry, Bradford C. Dickerson, Murray Grossman, Holly Soares, Margaret Sutherland, Debra Niehoff, Brian M. Alexander, Susan Dickinson, Frances McFarland, Michael A. Panzara, Howard Feldman, Adam L. Boxer, Edward D. Huey
Publikováno v:
Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1
Alzheimers Dement
Alzheimers Dement
Introduction Frontotemporal lobar degeneration (FTLD) is the most common form of dementia for those under 60 years of age. Increasing numbers of therapeutics targeting FTLD syndromes are being developed. Methods In March 2018, the Association for Fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b53137986dcbcc98368f65c3a2818b4
https://escholarship.org/uc/item/13t6f67b
https://escholarship.org/uc/item/13t6f67b
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease public-private partnership develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cc70696537623087c4b52e1330ceee
https://doi.org/10.1016/j.trci.2017.08.003
https://doi.org/10.1016/j.trci.2017.08.003
Autor:
Eric M. Reiman, Hugo Vanderstichele, Steve Broadbent, Klaus Romero, Ethan Wilson, Jon Neville, Martin Cisneroz, Elizabeth LeRoy, Brian Corrigan, Bob Stafford, Stephen P. Arneric, Diane Stephenson, Steve Kopko
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction The exceedingly high rate of failed trials in Alzheimer's disease (AD) calls for immediate attention to improve efficiencies and learning from past, ongoing, and future trials. Accurate, highly rigorous standardized data are at the core
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec5d1f1e3be80386fc2cd5ab2ea8caa
http://europepmc.org/articles/PMC5651436
http://europepmc.org/articles/PMC5651436
Autor:
Stephen P. Arneric, Diane Stephenson
Central nervous system (CNS) diseases represent one of the most challenging therapeutic areas for successful drug approvals. Developing biomarkers as drug development tools (DDTs) that catalyze the path to innovative treatments can aid in reducing th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::578b5500d78e8844275ed653d3cb1cf2
https://doi.org/10.1016/b978-0-12-803161-2.00020-5
https://doi.org/10.1016/b978-0-12-803161-2.00020-5
Autor:
Stephen P. Arneric, Lisa H. Gold, Klaus Romero, Stacie Weninger, Volker D. Kern, Martha Brumfield, Billy Dunn, Maria C. Carrillo
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ea9046d7dca9459845d33ecbfd8483a
https://doi.org/10.1016/j.jalz.2018.06.2493
https://doi.org/10.1016/j.jalz.2018.06.2493
Autor:
Patricia E. Cole, Dawn C. Matthews, Klaus Romero, Danny Chen, Zhiyong Xie, Robin Wolz, Daniela J. Conrado, Timothy Nicholas, Vikram Sinha, Wenping Wang, Brian A. Willis, Derek L. G. Hill, James Hendrix, Volker D. Kern, Julie A. Stone, Lisa H. Gold, Jackson Burton, Stephen P. Arneric, Mark Forrest Gordon, Gerald Novak
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07c6615f8cc16bbef2fbdc69a1236c6d
https://doi.org/10.1016/j.jalz.2018.06.1386
https://doi.org/10.1016/j.jalz.2018.06.1386
Autor:
Billy Dunn, Volker D. Kern, Klaus Romero, Stephen P. Arneric, Martha Brumfield, Daniela J. Conrado, Michael Gold, Samantha Budd Haeberlein
Publikováno v:
Alzheimer's & Dementia. 15:P1376-P1377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7cf7a89c8e0213f6b4305a4a01923a1
https://doi.org/10.1016/j.jalz.2019.06.3922
https://doi.org/10.1016/j.jalz.2019.06.3922
Publikováno v:
Biochemical pharmacology. 151
Central Nervous System (CNS) diseases represent one of the most challenging therapeutic areas for successful drug approvals. Developing quantitative biomarkers as Drug Development Tools (DDTs) can catalyze the path to innovative treatments, and impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ce37acfa3271d294469fc68d694ffa
https://pubmed.ncbi.nlm.nih.gov/29410157
https://pubmed.ncbi.nlm.nih.gov/29410157
Autor:
Jesse M. Cedarbaum, Michael T. Ropacki, Lynn D. Hudson, Spyros Papapetropoulos, Cheryl Fitzer-Attas, George Vradenburg, Penny A. Dacks, Jane Rhodes, Volker D. Kern, Klaus Romero, Jeffrey Kaye, Mark Forrest Gordon, Maurizio F. Facheris, Sean Khozin, Jian Wang, Derek L. G. Hill, Rhoda Au, Daniel R. Karlin, Stephen P. Arneric, Ottavio V. Vitolo, Bradley Miller
Publikováno v:
Nature reviews. Drug discovery. 16(10)
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b4cdc9b730c4b83c257276072e3fc7c
https://pubmed.ncbi.nlm.nih.gov/28935908
https://pubmed.ncbi.nlm.nih.gov/28935908
Autor:
Kaori Ito, Gerald Novak, Mahesh N. Samtani, Daniela J. Conrado, Richard Meibach, Mark Forrest Gordon, Dawn C. Matthews, Zhiyong Xie, Volker D. Kern, Timothy Nicholas, Stephen P. Arneric, Julie A. Stone, Danny Chen, Derek L. G. Hill, Patricia E. Cole, Brian A. Willis, Adam J. Schwarz, Vikram Sinha, Brian Corrigan, Klaus Romero
Publikováno v:
Alzheimer's & Dementia. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4f211311b283d7435a054be02d71917
https://doi.org/10.1016/j.jalz.2017.06.1878
https://doi.org/10.1016/j.jalz.2017.06.1878